One of the “trickiest parts” about children receiving gender-affirming hormone therapy is the likelihood that they will be infertile, according to Dr. Kathryn Lowe, a fellow with the American Academy of Pediatrics (AAP).
The remark was made at an annual meeting of the Wisconsin AAP in May and recirculated online on Dec. 6.
Noting that current research on the topic is limited, Lowe advised: “What we do know is these kids probably will be infertile. So, it’s really crucial to have multiple conversations with the family about that.”
Despite that admission, when questioned about the potential long-term harms to a child’s sexual development and function, Lowe went on to claim that without hormone therapy as an option, some children would resort to self-harm….